Health

Judi Health, a health technology company and benefits administrator, launched a new Medicare Part D plan on Tuesday called Judi Rx Retire. New York-based Judi Health, previously known as Capital …

As generative AI moves toward performing increasingly consequential clinical functions, the American Medical Association (AMA) is urging the U.S. Food and Drug Administration to address a foundational question: Who is …

GSK’s top-selling cancer product is expanding its approval to include advanced cases of rectal cancer, bringing eligible patients the option of treatment with an immunotherapy that could avoid the need …

Readily, an AI compliance intelligence platform for healthcare, announced last week that it secured $11 million in Series A funding. San Francisco-based Readily helps health plans and other organizations manage …

At an in-depth panel discussion Tuesday at The MedTech Conference hosted by the industry group AdvaMed in Boston, Rick Abramson said something very interesting on the future of AI regulation. …

In the Tragedy of the Commons, an invaluable resource is destroyed by the very parties who depend on it — not out of malice or neglect but by acting in …

Phantom GI, a Tel Aviv-based medical startup, launched out of stealth last week, with a $5 million seed round led by Pitango Healthcare, with participation from RAD Biomed and RUNI …

Merck KGaA is acquiring Silence Therapeutics in a $1.1 billion deal that comes with a Phase 3-ready drug offering the potential to stand out in an emerging class of new …

Tariffs, FDA user-fee programs, clearer payment and coverage rules and cybersecurity are top of mind for AdvaMed, according to Scott Whitaker, president and CEO of the organization. Whitaker made these …

I woke up one Saturday morning with double vision. Of course I wanted to know why it was happening. But three other questions were more urgent: What kind of doctor …